Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Szabolcs Szatmári"'
Autor:
Szabolcs Szatmári, József Attila Szász, Károly Orbán-Kis, Simona Bataga, Marius Ciorba, Előd Nagy, Radu Neagoe, István Mihály, Péter Zsombor Szász, Krisztina Kelemen, Attila Frigy, Andrea Csipor-Fodor, Viorelia Adelina Constantin
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Continuous intra-jejunal infusion of levodopa-carbidopa intestinal gel (LCIG) is a long-term proven and effective treatment in advanced Parkinson’s Disease (APD). Efficacy and safety of 16-h administration of LCIG has already been establis
Externí odkaz:
https://doaj.org/article/55616b6a961c47e9a21edc3a367df968
Autor:
Szabolcs Szatmári, József Attila Szász, Károly Orbán-Kis, Beáta Baróti, Simona Bataga, Marius Ciorba, Előd Ernő Nagy, Radu Mircea Neagoe, István Mihály, Péter Zsombor Szász, Krisztina Kelemen, Attila Frigy, Mónika Szilveszter, Viorelia Adelina Constantin
Publikováno v:
Pharmaceutics, Vol 16, Iss 4, p 453 (2024)
Levodopa–entacapone–carbidopa intestinal gel infusion is a relatively new treatment option for advanced Parkinson’s disease. We aimed to describe and analyze the characteristics of de novo levodopa–entacapone–carbidopa intestinal gel therap
Externí odkaz:
https://doaj.org/article/14b4fec2497743729dc9ba6599adfd6b
Autor:
Tímea Tünde Takács, Ádám József Berki, Péter Pál Böjti, Rita Stang, Pablo Antonio Fritz-Reunes, Luiz Schnekenberg, Timo Siepmann, Alexandra Pintér, Szabolcs Szatmári, Dániel Bereczki, Bence Gunda
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Background Acute ischemic stroke (AIS) is a common complication of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection (COVID-19), but the prognosis of these patients is poorly understood. Purpose To explore the impact of COVID
Externí odkaz:
https://doaj.org/article/d20845d45d3240e39a8871f50e5a50cb
Autor:
Krisztina Kelemen, Attila Kövecsi, Laura Banias, Izolda Klára, István Mihály, Csilla Forró, József Attila Szász, Szabolcs Szatmári
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 16, p 4803 (2022)
Creutzfeldt–Jacob disease is a progressive and ultimately fatal disease, representing one of the most common forms of prion diseases. It is a rare pathology presenting with various symptomatology, and the fact that a definite diagnosis can be obtai
Externí odkaz:
https://doaj.org/article/8e5fb7a245f744ffb707ad0f9f68c980
Autor:
József Attila Szász, Viorelia Adelina Constantin, Károly Orbán-Kis, Ligia Ariana Bancu, Simona Maria Bataga, Marius Ciorba, Előd Nagy, Mircea Radu Neagoe, István Mihály, Róbert Máté Szász, Krisztina Kelemen, Mihaela Simu, Szabolcs Szatmári
Publikováno v:
Pharmaceutics, Vol 14, Iss 6, p 1115 (2022)
Advanced Parkinson’s disease (APD) cannot be treated efficiently using the classical medications however, in recent decades invasive therapeutical methods were implemented and confirmed as effective. One of these methods makes it possible to contin
Externí odkaz:
https://doaj.org/article/083d8f308d494187a5a13bbd7b8622f7
Autor:
Timo Siepmann, Martin Arndt, Annahita Sedghi, Szabolcs Szatmári, Tamás Horváth, Annamária Takáts, Dániel Bereczki, Mats Leif Moskopp, Sylvia Buchmann, Cornelia Skowronek, Wagner Zago, Warunya Woranush, Razvan Lapusca, Marie Luise Weidemann, Christopher H. Gibbons, Roy Freeman, Heinz Reichmann, Volker Puetz, Kristian Barlinn, Alexandra Pintér, Ben Min‐Woo Illigens
Publikováno v:
European Journal of Neurology. 30:1281-1292
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0236728 (2020)
ObjectivesPsychiatric symptoms (PS) can be non-motor features in Parkinson's disease (PD) which are common even in the prodromal, untreated phase of the disease. Some PS, especially depression and anxiety recently became known predictive markers for
Externí odkaz:
https://doaj.org/article/5a5f1bc4f691423aa59d86ef2f9b55b2
Autor:
József Attila Szász, Viorelia Adelina Constantin, Károly Orbán-Kis, Ligia Ariana Bancu, Marius Ciorba, István Mihály, Előd Ernő Nagy, Róbert Máté Szász, Krisztina Kelemen, Mihaela Adriana Simu, Szabolcs Szatmári
Publikováno v:
Brain Sciences, Vol 11, Iss 7, p 826 (2021)
Background: In the advanced stages of Parkinson’s disease (APD), complex forms of dyskinesia may severely impair the patient’s quality of life. Objective: In the present study, we aimed to analyze the evolution under LCIG therapy of the most impo
Externí odkaz:
https://doaj.org/article/808c1a934ad04985ba21eaa34bb01c67
Autor:
Szabolcs Szatmári, András Ajtay, Mónika Bálint, Annamária Takáts, Ferenc Oberfrank, Dániel Bereczki
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Objectives: We set forth to estimate the number of those with Parkinson's disease (PD) in Hungary, a country with a single-payer health insurance system covering 10 million inhabitants.Methods: We analyzed all hospital and outpatient reports from neu
Externí odkaz:
https://doaj.org/article/bdde7b31568643efaf84b266fea9e836
Döntési szempontok és az eszközös terápia elfogadásához szükséges idő előrehaladott Parkinson-kórban
Autor:
Attila Rácz, Előd Ernő Nagy, Krisztina Kelemen, Viorelia Adelina Constantin, Emőke Almásy, József Attila Szász, Attila Frigy, Károly Orbán-Kis, Szabolcs Szatmári, István Mihály, Timea Forró
Publikováno v:
Orvosi Hetilap. 162:839-847
Összefoglaló. Bevezetés: Az előrehaladott Parkinson-kór bizonyos fázisában a motoros komplikációk már nem befolyásolhatók hatékonyan a hagyományos orális, illetve transdermalis gyógyszerekkel. Ilyenkor meg kell fontolni, komplex felm